Re: Regional citrate anticoagulation does not prolong filter survival during CVVH

Journal of Critical Care

Volumn 21, Issue 3, 2006, Pages 291-292

  Spronk, Peter E ^a,b   Steenbergen, Hans ^a   ten Kleij, Marianne ^a   Rommes, Johannes H ^a  

^a GELRE HOSPITALS   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; CITRATE SODIUM; HEPARIN; LACTIC ACID;

ABSENCE OF SIDE EFFECTS; ANTICOAGULATION; BLEEDING; CONTINUOUS HEMOFILTRATION; DIALYSATE; FILTER; HEMATOCRIT; HEMODIAFILTRATION; HUMAN; INTENSIVE CARE UNIT; LETTER; PROTHROMBIN TIME; STATISTICAL ANALYSIS; SURVIVAL TIME; THROMBOCYTE COUNT; ULTRAFILTRATION;

ANTICOAGULANTS; CITRATES; HEMOFILTRATION; HUMANS;

EID: 33748611903     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrc.2006.02.002     Document Type: Letter

References (4)

1. Bagshaw S.M., Laupland K.B., Boiteau P.J., and Godinez-Luna T. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system. J Crit Care 20 (2005) 155-161
2. Dehua G., Daxi J., Honglong X., et al. Trisodium citrate combined with low dosage of low molecular weight heparin anticoagulation in continuous venovenous hemofiltration. [Abstract]. Blood Purif 20 (2002) 305-323
3. Schetz M. Anticoagulation in continuous renal replacement therapy. Contrib Nephrol (2001) 283-303
4. Brophy P.D., Somers M.J., Baum M.A., Symons J.M., McAfee N., Fortenberry J.D., et al. Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT). Nephrol Dial Transplant 20 (2005) 1416-1421